94232 ⎘
Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Oxygen or sulfur atoms One oxygen atom
Sub-classes:TETRAHYDRO-1H-CYCLOPENTA[CD]INDENE DERIVATIVES AS HYPOXIA INDUCIBLE FACTOR-2(ALPHA) INHIBITORS
#2COMPOUNDS AND METHODS OF THEIR USE
#3TETRAHYDRO-1H-CYCLOPENTA[CD]INDENE DERIVATIVES AS HYPOXIA INDUCIBLE FACTOR-2(ALPHA) INHIBITORS
#4CLEAVABLE AGENTS
#5Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
#6TETRAHYDRO-1H-CYCLOPENTA[CD]INDENE DERIVATIVES AS HYPOXIA INDUCIBLE FACTOR-2(ALPHA) INHIBITORS
#7Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2α inhibitors
#8α,β-unsaturated amide compound
#9Labile esters of agrochemicals for controlled release and reduction of off-site movement
#10TETRAHYDRO-1H-CYCLOPENTA[CD]INDENE DERIVATIVES AS HYPOXIA INDUCIBLE FACTOR-2(ALPHA) INHIBITORS
#11Therapeutic compounds as inhibitors of the orexin-1 receptor
#12Cleavable agents
#13Guanidine derivative and medical use thereof
#14N-SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF
#15Labile esters of agrochemicals for controlled release and reduction of off-site movement
#16Vicinal primary diamines associated with metal and/or free radical chelation motifs, and active against carbonyl and oxidative stress, and use thereof
#17Therapeutic compounds as inhibitors of the orexin-1 receptor
#18Antifungal oxodihydropyridinecarbohydrazide derivative
#19Compounds useful as immunomodulators
#20C-H fluorination of heterocycles with silver (II) fluoride
#21Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
#22N-substituted benzamides and methods of use thereof
#23Labile esters of agrochemicals for controlled release and reduction of off-site movement
#24Compounds and methods for treating inflammatory and fibrotic disorders
#25Method of modulating stress-activated protein kinase system
#26Thionating agent
#27Synthetic ion channels
#28Method for production of F-18 labeled amyloid beta ligands
#29Thionation process and a thionating agent
#30Compounds and methods for treating inflammatory and fibrotic disorders
#31Pyridinone hydroxycyclopentyl carboxamides: HIV integrase inhibitors with therapeutic applications
#32Method of modulating stress-activated protein kinase system
#332,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
#34Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents
#35TOLUIDINE SULFONAMIDES AND THEIR USE
#36NEW PYRIDONE DERIVATES WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS
#37Sulfonamide derivatives as Nav 1.7 inhibitors
#38RESIST COMPOSITION FOR SEMICONDUCTOR, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME
#394-pyridinone compounds and their use for cancer
#40PHENETHYLAMIDE DERIVATIVES AND THEIR HETEROCYCLIC ANALOGUES
#41Heterocyclic antiviral compounds
#42FUNGICIDAL PYRIDINES
#43Therapeutic compounds
#44Fungicidal compounds, method for the production thereof, and use thereof to combat damaging fungi, and agents comprising the same
#452,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
#46METHOD OF MODULATING STRESS-ACTIVATED PROTEIN KINASE SYSTEM
#47Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
#48Compounds and methods for treating inflammatory and fibrotic disorders
#49Six-membered heterocycles useful as serine protease inhibitors
#50Btk protein kinase inhibitors
#51Novel Curcuminoid-Factor VIIA Constructs as Suppressors of Tumor Growth and Angiogenesis
#52Pyridone derivates with MCH antagonistic activity and medicaments comprising these compounds
#53RAF KINASE INHIBITORS CONTAINING A ZINC BINDING MOIETY
#54Curcumin analogs with anti-tumor and anti-angiogenic properties
#55PIM KINASE INHIBITORS AS CANCER CHEMOTHERAPEUTICS
#56Synthetic ion channels
#57Substituted picolinamides as MAO-B inhibitors useful for treating obesity
#58Compounds for modulating cell proliferation
#59Method of modulating stress-activated protein kinase system
#60Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders
#61Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis
#62Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
#632,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties
#64β-lactamase inhibitors and methods of use thereof
#65Cytotoxic compound-protein conjugates as suppressors of tumor growth and angiogenesis